https://www.selleckchem.com/pr....oducts/pterostilbene
In this pragmatic trial involving patients with established cardiovascular disease, there was substantial dose switching to 81 mg of daily aspirin and no significant differences in cardiovascular events or major bleeding between patients assigned to 81 mg and those assigned to 325 mg of aspirin daily. (Funded by the Patient-Centered Outcomes Research Institute; ADAPTABLE ClinicalTrials.gov number, NCT02697916.). Surgical occlusion of the left atrial appendage has been hypothesized to prevent ischemic stroke in patients with atrial
Curtir
Comentario
Compartilhar
